AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Core Insights - AbCellera will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 [1] - A live audio webcast of the presentation will be available on AbCellera's Investor Relations website, with a replay accessible afterward [1] Company Overview - AbCellera is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines [2] - The company's areas of focus include endocrinology, women's health, immunology, and oncology [2] - More information about the company can be found on their website [2]